Archives

by in
Entry Author Date Location
Alzheimer’s R&D Isn’t Doomed, it’s Learning From Failure 08/20/12 National
Innovimmune Pursues Pharma Partners, Shuns VCs 08/07/12 New York
U.S. Biotech Clusters Are Losing Their Anchor Tenants, and It Hurts 08/06/12 National
Enlight Bio’s Knode Advances Social Network for Pharma 08/02/12 Boston
Gladstone, Sage Bionetworks Top ‘Best Places to Work’ List 08/01/12 National
Actinium Advances Armed Cancer Drugs, Preps for Wall Street Debut 08/01/12 New York
Bristol-Myers Buys Amylin for $5.3B, Getting Diabetes Drugs 06/29/12 San Diego
Clash of the BioPharma Titans Looms Over Biosimilars 06/25/12 National
SD Life Sciences Roundup: Ambrx Gets Big Partner, GenMark, & More 06/21/12 National
Merck Bets $15M on Ambrx’s “Smart Bomb” Antibodies 06/18/12 San Diego
Merck Sleep Drug Hits Trial Goals, Raising Hopes for New Blockbuster 06/13/12 New York
FDA Rejects Ariad/Merck Sarcoma Pill, Wall Street Unfazed 06/06/12 New York
ASCO Wrap-Up: A Summary of This Week’s Cancer R&D Headlines 06/05/12 National
Merck Oncology Chief Heads to ASCO With High Hopes for New Drugs 05/31/12 New York
The 2012 New York ASCO Checklist 05/24/12 New York
What Are the Hottest Targets in Biotech Today? 04/23/12 National
Dyax, Adimab, Mersana, & More Boston Life Sciences Newsmakers 04/20/12 Boston
Alder Biopharma Snags $38M To Charge Ahead With Antibody Drugs 04/19/12 Seattle
Sage Bionetworks Moves from Thinking Stage to Doing Stage 04/18/12 San Francisco
AisleBuyer, Crashlytics, Cymfony, & More Boston Dealmakers 04/11/12 Boston
Investing in Biotech Isn’t Just for Investors Anymore 04/09/12 National
DecisionView Looks to Help Speed Up Pharma’s Painfully Slow Trials 03/27/12 San Francisco
Life Sciences News: Slow-Growing Valuations & Merck/Ariad Drug 03/23/12 Boston
Ariad and Merck Face Tough FDA Review of Sarcoma Pill 03/20/12 Boston
Biotech’s New Frontier: Europe? 03/19/12 National
Peter Schultz on New Merck-Funded Institute: ‘We’re Getting Lots of Resumes’ 03/16/12 San Diego
Merck Returns to SD, Pouring $90M Into New Schultz-Led Institute 03/15/12 San Diego
Satori Cultivates Prolific Herb for Promising Alzheimer’s Weapon 02/28/12 Boston
Enanta Enters HepC Big Leagues, With $34M Upfront From Novartis 02/21/12 Boston
Vertex Vows to Fight On With Alios Drugs in High-Stakes Hepatitis C Race 01/24/12 Boston
Page 2 of 13 « previous page · next page »

Xconomy Events Across the Network

The Napa Summit 2013: New Rules for Growth

San Francisco · 6/3/13

More Xconomy Events

Xconomy’s Most Popular

  1. Venture Funding Slows as VC Industry Contracts, & Top 10 Deals List
  2. Henri Termeer on Startups, Drug Prices, Getting Older (Part 1)
  3. Xconomy Opens in Texas, Expanding Roundup of Innovation Across U.S.
  4. Do You Need an Extended Warranty? Do the Math, Says SquareTrade
  5. When iMovie Isn’t Enough, Amateur Video Producers Can Go Pro

Xconomy on Demand

Did you miss something? Don't despair…

Xconomy offers a number of ways to subscribe for free!

Subscribe Now
IDG Tech Network
Protected by Mozy
Eventbrite - events made easy

Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit, San Francisco, New York, Boulder/Denver, Texas and beyond.

© 2007-2013, Xconomy, Inc. Xconomy is a registered service mark of Xconomy, Inc. All rights reserved.

Website development support from Andrew Koyfman with design support from Rob Hunter.